BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24062073)

  • 21. The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner.
    Curran NM; Griffin BD; O'Toole D; Brady KJ; Fitzgerald SN; Moynagh PN
    J Biol Chem; 2005 Oct; 280(43):35797-806. PubMed ID: 16105834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling.
    Su SH; Wu YF; Lin Q; Yu F; Hai J
    Neuroscience; 2015 Aug; 301():563-75. PubMed ID: 25795598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2.
    Zhang G; Bi H; Gao J; Lu X; Zheng Y
    Cell Biochem Funct; 2016 Jul; 34(5):351-8. PubMed ID: 27309350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
    Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
    Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid receptor agonist WIN-55,212-2 protects differentiated PC12 cells from organophosphorus- induced apoptosis.
    Sadri S; Bahrami F; Khazaei M; Hashemi M; Asgari A
    Int J Toxicol; 2010; 29(2):201-8. PubMed ID: 20335515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.
    Sánchez AJ; González-Pérez P; Galve-Roperh I; García-Merino A
    Biochem Pharmacol; 2006 Dec; 72(12):1697-706. PubMed ID: 17007821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
    Cao LQ; Shao ZL; Liang HH; Zhang DW; Yang XW; Jiang XF; Xue P
    Cancer Lett; 2015 Apr; 359(1):127-35. PubMed ID: 25592041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis.
    Notaro A; Sabella S; Pellerito O; Di Fiore R; De Blasio A; Vento R; Calvaruso G; Giuliano M
    Int J Biol Sci; 2014; 10(5):466-78. PubMed ID: 24795528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.
    Wang K; Wang Q; Li Q; Zhang Z; Gao J; Fan C; Sun B; Ni Q
    Biomed Res Int; 2021; 2021():6612592. PubMed ID: 33977107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WIN55,212-2-Induced Expression of Mir-29b1 Favours the Suppression of Osteosarcoma Cell Migration in a SPARC-Independent Manner.
    Notaro A; Emanuele S; Geraci F; D'Anneo A; Lauricella M; Calvaruso G; Giuliano M
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of bcl-xL gene expression.
    Pozzoli G; Tringali G; Vairano M; D'Amico M; Navarra P; Martire M
    J Neurosci Res; 2006 May; 83(6):1058-65. PubMed ID: 16609959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft.
    Scuderi MR; Cantarella G; Scollo M; Lempereur L; Palumbo M; Saccani-Jotti G; Bernardini R
    Cancer Lett; 2011 Nov; 310(2):240-9. PubMed ID: 21807457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
    Scholl A; Ivanov I; Hinz B
    Oncotarget; 2016 Sep; 7(38):61438-61457. PubMed ID: 27556861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid receptor as a novel target for the treatment of prostate cancer.
    Sarfaraz S; Afaq F; Adhami VM; Mukhtar H
    Cancer Res; 2005 Mar; 65(5):1635-41. PubMed ID: 15753356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antineoplastic effect of WIN 55,212-2, a cannabinoid agonist, in a murine xenograft model of gastric cancer.
    Oh JH; Lee JY; Baeg MK; Han KH; Choi MG; Park JM
    Chemotherapy; 2013; 59(3):200-6. PubMed ID: 24335109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2.
    Payandemehr B; Ebrahimi A; Gholizadeh R; Rahimian R; Varastehmoradi B; Gooshe M; Aghaei HN; Mousavizadeh K; Dehpour AR
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():140-5. PubMed ID: 25448777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ONTD induces growth arrest and apoptosis of human hepatoma Bel-7402 cells though a peroxisome proliferator-activated receptor γ-dependent pathway.
    Tan J; Shen W; Shi W; Chen X; Sun D; Xu C; Yan Q; Cheng H; Lai Y; Ji H
    Toxicol In Vitro; 2017 Dec; 45(Pt 1):44-53. PubMed ID: 28834734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
    Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
    Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.
    Preet A; Qamri Z; Nasser MW; Prasad A; Shilo K; Zou X; Groopman JE; Ganju RK
    Cancer Prev Res (Phila); 2011 Jan; 4(1):65-75. PubMed ID: 21097714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
    Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
    Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.